STTK Q4 2022 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$291M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$390,000-98.7% YoY

Gross Profit

-$21M-5332.6% margin

Operating Income

-$26M-6737.4% margin

Net Income

-$25M-6515.6% margin

EPS (Diluted)

$-0.58

QoQ Revenue Growth

+84.0%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$25M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$205M

Total Liabilities

$29M

Stockholders' Equity

$176M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$390,000	$30M	-98.7%
Gross Profit	-$21M	$14M	-249.9%
Operating Income	-$26M	$9M	-384.2%
Net Income	-$25M	$8M	-423.8%